SMMT

Summit Therapeutics Inc.

Insider Trades

NameValueActionPriceCurrent Price
Zanganeh MahkamDirector, 10 Percent Owner, Officer: Co-Chief Executive Officer
$1.5M100k shares
BuyJun 4, 2026
$14.60
--
Duggan Robert WDirector, 10 Percent Owner, Officer: Co-Chief Executive Officer
$1.5M100k shares
BuyJun 4, 2026
$14.60
--
Soni Manmeet SinghDirector, Officer: COO And CFO
$362k25k shares
BuyJun 4, 2026
$14.46
--
Soni Manmeet SinghDirector, Officer: COO And CFO
$361k25k shares
BuyJun 4, 2026
$14.43
--
Xia YuDirector
$10.0M533.6k shares
BuyOct 21, 2025
$18.74
--
Duggan Robert WDirector, 10 Percent Owner, Officer: Co-Chief Executive Officer
$500k26.7k shares
BuyOct 21, 2025
$18.74
--

News

businesswire.comSummit Therapeutics Announces Proposed Public Offering of Common Stockbusinesswire.comJun 9seekingalpha.comSummit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 8247wallst.comMizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech247wallst.comJun 7wsj.comThe Era of the One-Size-Fits-All Cancer Drug Is Endingwsj.comJun 6businesswire.comSummit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conferencebusinesswire.comJun 4